- Record: found
- Abstract: not found
- Article: not found
Beta Blockers in Critically Ill Patients with Traumatic Brain Injury : Results from a Multi-Center, Prospective, Observational AAST Study
Eric J. Ley ,
Samuel D. Leonard ,
Galinos Barmparas ,
Navpreet K. Dhillon ,
Kenji Inaba ,
Ali Salim ,
Karen R. OʼBosky ,
Danielle Tatum ,
Hooman Azmi ,
Chad G. Ball ,
Paul T. Engels ,
Julie A. Dunn ,
Matthew M. Carrick ,
Jonathan P. Meizoso ,
Sarah Lombardo ,
Bryan A. Cotton ,
Thomas J. Schroeppel ,
Sandro Rizoli ,
David S. J. Chang ,
Luis Alejandro de León ,
Joao Rezende-Neto ,
Tomas Jacome ,
Jimmy Xiao ,
Gina Mallory ,
Krishnamurti Rao ,
Lars Widdel ,
Samuel Godin ,
Angela Coates ,
Leo Andrew Benedict ,
Raminder Nirula ,
Sanjeev Kaul ,
Tong Li
December 2017
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
<p class="first" id="d8797689e243">Beta blockers, a class of medications that inhibit
endogenous catecholamines interaction
with beta adrenergic receptors, are often administered to patients hospitalized after
traumatic brain injury (TBI). We tested the hypothesis that beta blocker use after
TBI is associated with lower mortality, and secondarily compared propranolol to other
beta blockers.
</p>